Caligan Partners LP Diversified Active

CIK: 0001727492 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $479,229 (100.0% shares, 0.0% debt)

Holdings (16)

LQDA LIQUIDIA CORPORATION 25.0%

Value ($000) $119,749 Shares 8,118,592 Est. Cost $5.57 Unrealized +161.8%

— VERONA PHARMA PLC 19.0%

Value ($000) $91,227 Shares 1,436,878 Est. Cost $16.60 Unrealized —

EXEL EXELIXIS INC 11.8%

Value ($000) $56,330 Shares 1,525,730 Est. Cost $19.42 Unrealized +83.5%

MLYS MINERALYS THERAPEUTICS INC 7.1%

Value ($000) $34,137 Shares 2,149,667 Est. Cost $11.97 Unrealized -3.9%

EOLS EVOLUS INC 6.9%

Value ($000) $32,856 Shares 2,731,154 Est. Cost $10.65 Unrealized +22.8%

— SAGE THERAPEUTICS INC 5.1%

Value ($000) $24,268 Shares 3,052,538 Est. Cost $5.43 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 4.9%

Value ($000) $23,308 Shares 3,107,669 Est. Cost $5.90 Unrealized +36.7%

ANIK ANIKA THERAPEUTICS INC 4.5%

Value ($000) $21,570 Shares 1,435,130 Est. Cost $25.57 Unrealized -34.9%

AGIO AGIOS PHARMACEUTICALS INC 4.3%

Value ($000) $20,548 Shares 701,280 Est. Cost $28.21 Unrealized +17.6%

RVMD REVOLUTION MEDICINES INC 3.4%

Value ($000) $16,442 Shares 465,000 Est. Cost $40.59 Unrealized 0.0%

— MERUS N V 3.3%

Value ($000) $15,866 Shares 376,954 Est. Cost $42.06 Unrealized —

— Y-MABS THERAPEUTICS INC 2.2%

Value ($000) $10,378 Shares 2,342,609 Est. Cost $8.13 Unrealized —

ABVX ABIVAX SA 1.7%

Value ($000) $7,932 Shares 1,269,119 Est. Cost $6.88 Unrealized —

— VERRICA PHARMACEUTICALS INC 0.8%

Value ($000) $3,977 Shares 8,992,954 Est. Cost $0.66 Unrealized —

RZLT REZOLUTE INC 0.1%

Value ($000) $410 Shares 141,309 Est. Cost $4.35 Unrealized 0.0%

TYRA TYRA BIOSCIENCES INC 0.0%

Value ($000) $233 Shares 25,000 Est. Cost $12.94 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LQDA	LIQUIDIA CORPORATION	8,118,592	$119,749	25.0%	$5.57	+161.8%	COM NEW	53635D202
—	VERONA PHARMA PLC	1,436,878	$91,227	19.0%	$16.60	—	SPONSORED ADS	925050106
EXEL	EXELIXIS INC	1,525,730	$56,330	11.8%	$19.42	+83.5%	COM	30161Q104
MLYS	MINERALYS THERAPEUTICS INC	2,149,667	$34,137	7.1%	$11.97	-3.9%	COM	603170101
EOLS	EVOLUS INC	2,731,154	$32,856	6.9%	$10.65	+22.8%	COM	30052C107
—	SAGE THERAPEUTICS INC	3,052,538	$24,268	5.1%	$5.43	—	COM	78667J108
BCRX	BIOCRYST PHARMACEUTICALS INC	3,107,669	$23,308	4.9%	$5.90	+36.7%	COM	09058V103
ANIK	ANIKA THERAPEUTICS INC	1,435,130	$21,570	4.5%	$25.57	-34.9%	COM	035255108
AGIO	AGIOS PHARMACEUTICALS INC	701,280	$20,548	4.3%	$28.21	+17.6%	COM	00847X104
RVMD	REVOLUTION MEDICINES INC	465,000	$16,442	3.4%	$40.59	0.0%	COM	76155X100
—	MERUS N V	376,954	$15,866	3.3%	$42.06	—	COM	N5749R100
—	Y-MABS THERAPEUTICS INC	2,342,609	$10,378	2.2%	$8.13	—	COM	984241109
ABVX	ABIVAX SA	1,269,119	$7,932	1.7%	$6.88	—	SPONSORED ADS	00370M103
—	VERRICA PHARMACEUTICALS INC	8,992,954	$3,977	0.8%	$0.66	—	COM	92511W108
RZLT	REZOLUTE INC	141,309	$410	0.1%	$4.35	0.0%	COM NEW	76200L309
TYRA	TYRA BIOSCIENCES INC	25,000	$233	0.0%	$12.94	0.0%	COM	90240B106